The findings suggest significant health benefits over the one-year course to women in this cohort as they had an abdominal obesity problem and by reducing WC may lower the risk of CVD and T2DM [30],whereas more reduction in fasting insulin level occurred in those who lost at least >2% weight compared to those who maintained or gained weight in the intervention group. The gene discussed is INS; the disease is type 2 diabetes mellitus.